Short_Name,Name,Institution,Target,Phase,Type,VH,VL,Sequence_Source
CoV_binder_1,REGN10933 (casirivimab),Regeneron,CoV-2,Phase 3,IGG,QVQLVESGGGLVKPGGSLRLSCAASGFTFSDYYMSWIRQAPGKGLEWVSYITYSGSTIYYADSVKGRFTISRDNAKSSLYLQMNSLRAEDTAVYYCARDRGTTMVPFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCQASQDITNYLNWYQQKPGKAPKLLIYAASNLETGVPSRFSGSGSGTDFTFTISGLQPEDIATYYCQQYDNLPLTFGGGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_2,REGN10987 (imdevimab),Regeneron,CoV-2,Phase 3,IGG,QVQLVESGGGVVQPGRSLRLSCAASGFTFSNYAMYWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCASGSDYGDYLLVYWGQGTLVTVSS,QSALTQPASVSGSPGQSITISCTGTSSDVGGYNYVSWYQQHPGKAPKLMIYDVSKRPSGVSNRFSGSKSGNTASLTISGLQSEDEADYYCNSLTSISTWVFGGGTKLTVL,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_3,"Bamlanivimab (LY3819253, LY-CoV555)",AbCellera/Eli Lilly/NIH,CoV-2,Phase 3,IGG,QVQLVQSGAEVKKPGSSVKVSCKASGGTFSNYAISWVRQAPGQGLEWMGRIIPILGIANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGYYEARHYYYYYAMDVWGQGTAVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSISSYLSWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTITSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_4,Regdanvimab (CT-P59),Celltrion,CoV-2,Phase 3,IGG,QITLKESGPTLVKPTQTLTLTCSFSGFSLSTSGVGVGWIRQPPGKALEWLALIDWDDNKYHTTSLKTRLTISKDTSKNQVVLTMTNMDPVDTATYYCARIPGFLRYRNRYYYYGMDVWGQGTTVTVSS,ELVLTQPPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAGVFGGGTELTVL,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_5,Sotrovimab (VIR-7831/GSK4182136),Vir biotechnology/GSK,CoV-2,Phase 3,IGG,QVQLVQSGAEVKKPGASVKVSCKASGYPFTSYGISWVRQAPGQGLEWMGWISTYQGNTNYAQKFQGRVTMTTDTSTTTGYMELRRLRSDDTAVYYCARDYTRGAWFGESLIGGFDNWGQGTLVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQTVSSTSLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQHDTSLTFGGGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_6,AZD8895/Tixagevimab/COV2-2196,AstraZeneca/Vanderbilt University Medical Center/DARPA/BARDA,CoV-2,Phase 3,IGG,QMQLVQSGPEVKKPGTSVKVSCKASGFTFMSSAVQWVRQARGQRLEWIGWIVIGSGNTNYAQKFQERVTITRDMSTSTAYMELSSLRSEDTAVYYCAAPYCSSISCNDGFDIWGQGTMVTVSS,EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQHYGSSRGWTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_7,AZD1061/Cilgavimab,AstraZeneca/Vanderbilt University Medical Center/DARPA/BARDA,CoV-2,Phase 3,IGG,EVQLVESGGGLVKPGGSLRLSCAASGFTFRDVWMSWVRQAPGKGLEWVGRIKSKIDGGTTDYAAPVKGRFTISRDDSKNTLYLQMNSLKTEDTAVYYCTTAGSYYYDTVGPGLPEGKFDYWGQGTLVTVSS,DIVMTQSPDSLAVSLGERATINCKSSQSVLYSSNNKNYLAWYQQKPGQPPKLLMYWASTRESGVPDRFSGSGSGAEFTLTISSLQAEDVAIYYCQQYYSTLTFGGGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_8,Etesevimab,"Junshi Biosciences/Institute of Microbiology, Chinese Academy of Sciences/Eli Lilly",CoV-2,Phase 2,IGG,EVQLVESGGGLVQPGGSLRLSCAASGFTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSMNTLFLQMNSLRAEDTAVYYCARVLPMYGDYLDYWGQGTLVTVSS ,DIVMTQSPSSLSASVGDRVTITCRASQSISRYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPPEYTFGQGTKLEIK,http://www.imgt.org/mAb-DB/mAbcard?AbId=1107
CoV_binder_9,COR-101 / STE90-C11,YUMAB /CORAT therapeutics,CoV-2,Phase 2,IGG,QVQLVESGGGLVQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTYYADSVKGRFTISRDDSKNTLYLQMNSLRAEDTAVYYCARDVADAFDIWGQGTMVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPFTFGPGTKVDIK,https://www.biorxiv.org/content/10.1101/2020.12.03.409318v1.full.pdf
CoV_binder_10,CC12.1,N/A,CoV-2,N/A,IGG,EVQLVESGGGLIQPGGSLRLSCAASGLTVSSNYMSWVRQAPGKGLEWVSVIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDLDVYGLDVWGQGTTVTVSS,DIVMTQSPSFLSASVGDRVTITCRASQGISSYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTEFTLTISSLQPEDFATYYCQQLNSYPPKFTFGPGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_11,Fab-52,N/A,CoV-2,N/A,IGG,QVQLVQSGAEVKKPGSSVKVSCKASGYTFTSYGISWVRQAPGQGLEWMGGIIPMFGTTNYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARDRGDTIDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQGISNNLNWYQQKPGKAPKLLIYAASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNGFPLTFGPGTKVDIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_12,BD23,N/A,CoV-2,N/A,IGG,QVQLVQSGSELKKPGASVKVSCKASGYTFTSYAMNWVRQAPGQGLEWMGWINTNTGNPTYAQGFTGRFVFSLDTSVSTAYLQISSLKAEDTAVYYCARPQGGSSWYRDYYYGMDVWGQGTTVTVSS,DIQMTQSPSTLSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYPYTFGQGTKLEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_13,m396-B10,N/A,CoV-2,N/A,IGG,QVQLQQSGAEVKKPGSSVKVSCKASGGTFSTYSISWVRQAPGQGLEWMGGIAPSHGFANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARDTATGGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDTYSDYVFGTGTKVTVL,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_14,CR3014-C8,N/A,CoV-2,N/A,IGG,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARGISPFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQYIYDSLNWYQQKPGKAPKLLIYDSSYLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSWDTPVTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_15,CR3014-D1,N/A,CoV-2,N/A,IGG,EVQLVESGGGLVQPGGSLRLSCAASGFTFSDHYMDWVRQAPGKGLEWVGRTRNKANSYTTEYAASVKGRFTISRDDSKNSLYLQMNSLKTEDTAVYYCARGISPFYFDYWGQGTLVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQDIAYALNWYQQKPGKAPKLLIYASSSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQMGREPTTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_16,CR3022-B6,N/A,CoV-2,N/A,IGG,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQMTQSPSSLSASVGDRVTITCRASQSIYSALNWYQQKPGKAPKLLIYAASALQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQTDIHPYTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_17,CR3022-B11,N/A,CoV-2,N/A,IGG,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLSDSIAKNYLAWYQQKPGQPPKLLIYWASSRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_18,CR3022-G11,N/A,CoV-2,N/A,IGG,QMQLVQSGTEVKKPGESLKISCKGSGYGFNYYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGDGVSTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLSYAVHKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_19,FC05,N/A,CoV-2,N/A,IGG,EVQLLEQSGAEVKKPGASVRVSCKVSGYTLPEVAMHWVRQAPGKGLEWMGGFDPEDGETMYAQKFQGRVTMTEDTSTDTAYMELSSLRSEDTAVYYCATTTPFSSSYWFDPWGQGTLVTV,SVLTQAPSVSAAPGQKVTISCSGSSSNIGNNYVSWYQQLPGTAPKLLIYDNNKRPSGIPDRFSGSKSGTSATLGITGLQTGDEADYYCGTWDSSLSAVVFGGGTKLTVL,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_20,P17,N/A,CoV-2,N/A,IGG,QQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHATLMNNKDIWGQGTLVTVSS,DIQLTQSPSSLSASVGDRVTITCRASQSISSYLNWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQSYSTPRTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_21,P4A1,N/A,CoV-2,N/A,IGG,EVQLVESGGGLIQPGGSLRLSCAASGFIVSSNYMSWVRQAPGKGLEWVSIIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCARDLQELGSLDYWGQGTLVTVSS,DIQMTQSPSSVSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYAASSLQSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQEANSFPYTFGQGTKLEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_22,S2-E12,N/A,CoV-2,N/A,IGG,QVQLVQSGPEVKKPGTSVRVSCKASGFTFTSSAVQWVRQARGQRLEWVGWIVVGSGNTNYAQKFHERVTITRDMSTSTAYMELSSLRSEDTAVYYCASPYCSGGSCSDGFDIWGQGTMVTVSS,DIVLTQTPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYVGLTGWTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_23,S2-M11,N/A,CoV-2,N/A,IGG,EVQLVQSGAEVKKPGASVKVSCKASGYTFTGYYMHWVRQAPGQGLEWMGWINPISSGTSYAQTFQGRVTMTSDTSITTAYMELSRLRSDDTAVYYCARAAPFYDFWSGYSYFDYWGQGTLVTVSS,EIVMMQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSAWTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_24,CR3022,N/A,CoV-1,N/A,IGG,QMQLVQSGTEVKKPGESLKISCKGSGYGFITYWIGWVRQMPGKGLEWMGIIYPGDSETRYSPSFQGQVTISADKSINTAYLQWSSLKASDTAIYYCAGGSGISTPMDVWGQGTTVTVSS,DIQLTQSPDSLAVSLGERATINCKSSQSVLYSSINKNYLAWYQQKPGQPPKLLIYWASTRESGVPDRFSGSGSGTDFTLTISSLQAEDVAVYYCQQYYSTPYTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_25,m396,N/A,CoV-1,N/A,IGG,QVQLQQSGAEVKKPGSSVKVSCKASGGTFSSYTISWVRQAPGQGLEWMGGITPILGIANYAQKFQGRVTITTDESTSTAYMELSSLRSEDTAVYYCARDTVMGGMDVWGQGTTVTVSS,SYELTQPPSVSVAPGKTARITCGGNNIGSKSVHWYQQKPGQAPVLVVYDDSDRPSGIPERFSGSNSGNTATLTISRVEAGDEADYYCQVWDSSSDYVFGTGTKVTVL,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_26,REGN-3051,N/A,Mers,N/A,IGG,EVQLVESGGGLVQPGGSLRLSCVVSGFTFSNYDMSWVRQAPGRGLEWVSAIRGSGFNTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDGSIVSMDYWGQGTLVTVSS,DIQMTQSPSALSASVGDRVTITCRASQSISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTEFTLTISSLQPDDFATYYCQQYNSYSWTFGQGTKVEIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_27,REGN-3048 ,N/A,Mers,N/A,IGG,EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGRGGNTYYADSVKGRFTISRDNSKNTLFLQMNTLRAEDTAVYYCAKDRGFGFFDIWGRGTLATVSS,DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKFLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPFTFGPGTKINIK,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_28,MR17,N/A,CoV-2,N/A,VHH,QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDDGQLAYHYDYWGQGTQVTVSS,N/A,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_29,VHH-72,N/A,CoV-2,N/A,VHH,QVQLQESGGGLVQAGGSLRLSCAASGRTFSEYAMGWFRQAPGKEREFVATISWSGGSTYYTDSVKGRFTISRDNAKNTVYLQMNSLKPDDTAVYYCAAAGLGTVVSEWDYDYDYWGQGTQVTVSS,N/A,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_30,Ty1,N/A,CoV-2,N/A,VHH,QVQLVETGGGLVQPGGSLRLSCAASGFTFSSVYMNWVRQAPGKGPEWVSRISPNSGNIGYTDSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCAIGLNLSSSSVRGQGTQVTVSS,N/A,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_31,Nb#6,N/A,CoV-2,N/A,VHH,QVQLVESGGGLVQAGGSLRLSCAASGYIFGRNAMGWYRQAPGKERELVAGITRRGSITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADPASPAYGDYWGQGTQVTVSS,N/A,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_32,VHH-21 ,N/A,Mers,N/A,VHH,EVQLQESGGGSVQTGGSLRLSCAASGSVYCMGWIRQAPGKEREGVARINSDGSVTYYGSSAKGRFSISRDSAKNTVTLLMNSLKPEDTAIYTCTAGTRKCMDLGSWIDFDYRGQGTQVTVSS,N/A,http://opig.stats.ox.ac.uk/webapps/covabdab/
CoV_binder_33,VHH-55,N/A,Mers,N/A,VHH,QVQLQESGGGSVQAGGSLRLSCVASGSIFSINAMDWYRQAPGKQRELVAGITSGGSTNYGDFVKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAAEVGGWGPPRPDYWGHGTQVTVSS,N/A,http://opig.stats.ox.ac.uk/webapps/covabdab/
